Login

CEO Andreas Thorsheim presents Otovo, a Norwegian startup offering a residential solar and battery marketplace, at Ecosummit Berlin 2023. 00:10:00

Share On Facebook Share On Twitter

Andreas Thorsheim is the Founder and CEO at Otovo 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Pathways Course Director (Integrated Human Pathophysiology III) / Melanie Hoenig, MD
00:10:00
Transatlantic Gains: How Lucerne Fund Leveraged European Growth for Record Returns | Mark Whelan - Fund Manager, Lucerne Capital Management
00:10:00
The Power of Guidance: How a Trusted Financial Coach Can Help You Navigate and Achieve Your Financial Goals with Dimensional Fund Advisors
00:10:00
Jean Case: Revolutionizing Investments for Profit and Impact | Jean Case - CEO of The Case Foundation
00:10:00
CJ Group Chairman Sohn Kyung-Shik Receives Van Fleet Award | Sohn Kyung Shik - CEO of the CJ Group
00:10:00
Bernard Aylwood, CEO of Codel Minerals: Pioneering Lithium Development in West Africa
00:10:00
Premier African Minerals: Driving Development and Growth in Zimbabwe's Resource Sector
00:10:00
Foord Asset Management marks over 40 years in the market, with the team reflecting on lessons learned and achievements.
00:10:00
The Future of Lending: Democratizing Finance with Rob Frohwein, CEO of Kabbage, and Charlie Wells, Wall Street Journal
00:10:00
Unveiling the Vision: Mario Gabril, CEO of GAMCO Investor | Mario J. Gabelli, Chief Executive Officer , Gamco Investors Inc.
00:10:00
Panorama Minerals: Advancing Copper Exploration Projects in Peru
00:10:00
Dätwyler Faces First-Half Profit Dip Due to Manchester Acquisition Costs, CEO Lambrecht Remains Upbeat for Future Growth

© 2026 Nehu